Search of: "Estramustine" - List Results

Home


	List Results


	Refine Search


	Results by Topic


	Results on Map


	Search Details

Found 48 studies with search of:

"Estramustine"

Hide studies that are not seeking new volunteers.

Display Options

1	Completed	Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer
		Conditions:	Hormone Resistant Prostate Cancer; Metastatic Prostate Cancer
		Interventions:	Drug: docetaxel; Drug: estramustine; Drug: prednisone

2	Active, not recruiting	Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment
		Conditions:	Adenocarcinoma of the Prostate; Prostate Cancer
		Interventions:	Drug: Docetaxel; Drug: Estramustine; Drug: Casodex; Drug: Zoladex

3	Recruiting	A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer
		Condition:	Prostate Cancer
		Interventions:	Drug: Epirubicin; Drug: Estramustine Phosphate; Drug: Celecoxib

4	Recruiting	Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate Cancer
		Condition:	Prostatic Neoplasms
		Interventions:	Drug: Docetaxel + Estramustine + Hydrocortisone; Drug: Docetaxel + Prednisone

5	Active, not recruiting	Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer
		Condition:	Prostate Cancer
		Interventions:	Drug: Docetaxel; Drug: Estramustine

6	Completed	Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy.
		Condition:	Prostate Adenocarcinoma
		Interventions:	Drug: Estramustine; Drug: Docetaxel; Drug: Carboplatin

7	Terminated	Phase I/II Study of IV Estramustine Combined With Taxol in Patients With Hormone Refractory Adenocarcinoma of the Prostate
		Condition:	Prostate Cancer
		Interventions:	Drug: Estramustine; Drug: Taxol

8	Active, not recruiting	Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinoma
		Condition:	Prostate Cancer
		Interventions:	Drug: Paclitaxel; Drug: Estramustine; Drug: Carboplatin

9	Active, not recruiting	Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer
		Condition:	Prostate Cancer
		Interventions:	Drug: Oral Estramustine; Drug: Oral Vinorelbine

10	Terminated	Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer
		Condition:	Prostate Cancer
		Intervention:	Drug: Doxil and Estramustine

11	Completed	Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
		Condition:	Prostate Cancer
		Interventions:	Drug: estramustine phosphate sodium; Drug: paclitaxel

12	Active, not recruiting	Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
		Condition:	Prostate Cancer
		Interventions:	Drug: doxorubicin hydrochloride; Drug: estramustine phosphate sodium; Procedure: drug resistance inhibition treatment

13	Completed	Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
		Condition:	Prostate Cancer
		Interventions:	Drug: carboplatin; Drug: docetaxel; Drug: estramustine phosphate sodium

14	Active, not recruiting	Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer
		Condition:	Breast Cancer
		Interventions:	Drug: docetaxel; Drug: estramustine phosphate sodium

15	Active, not recruiting	Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
		Condition:	Prostate Cancer
		Interventions:	Drug: estramustine phosphate sodium; Drug: paclitaxel

16	Active, not recruiting	Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
		Condition:	Prostate Cancer
		Interventions:	Drug: docetaxel; Drug: estramustine phosphate sodium

17	Completed	Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
		Condition:	Prostate Cancer
		Interventions:	Drug: estramustine phosphate sodium; Drug: paclitaxel

18	Terminated	Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma
		Condition:	Prostate Cancer
		Intervention:	Drug: Thalidomide, Taxol, Estramustine

19	Active, not recruiting	Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
		Condition:	Lymphoma
		Interventions:	Drug: estramustine phosphate sodium; Drug: paclitaxel

20	Completed	Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate
		Condition:	Prostate Cancer
		Interventions:	Drug: docetaxel; Drug: estramustine phosphate sodium; Drug: thalidomide

21	Completed	Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer
		Condition:	Prostate Cancer
		Interventions:	Drug: estramustine phosphate sodium; Drug: paclitaxel; Drug: topotecan hydrochloride

22	Active, not recruiting	Paclitaxel, Estramustine, and Thalidomide in Treating Patients With Progressive Metastatic Androgen-Independent Prostate Cancer
		Condition:	Prostate Cancer
		Interventions:	Drug: estramustine phosphate sodium; Drug: paclitaxel; Drug: thalidomide

23	Completed	Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer
		Condition:	Prostate Cancer
		Interventions:	Drug: estramustine phosphate sodium; Drug: ixabepilone

24	Active, not recruiting	Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
		Condition:	Prostate Cancer
		Interventions:	Drug: docetaxel; Drug: estramustine phosphate sodium; Drug: exisulind

25	Recruiting	Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
		Condition:	Prostate Cancer
		Interventions:	Drug: bicalutamide; Drug: buserelin; Drug: cyproterone acetate; Drug: docetaxel; Drug: estramustine phosphate sodium; Drug: flutamide; Drug: goserelin; Drug: leuprolide acetate; Drug: nilutamide; Drug: triptorelin; Procedure: conventional surgery; Procedure: neoadjuvant therapy; Procedure: radiation therapy

26	Active, not recruiting	Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
		Condition:	Prostate Cancer
		Interventions:	Drug: docetaxel; Drug: estramustine phosphate sodium; Drug: isotretinoin; Drug: recombinant interferon alfa-2b; Procedure: immunohistochemistry staining method; Procedure: polyacrylamide gel electrophoresis; Procedure: protein expression analysis

27	Active, not recruiting	Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate
		Condition:	Prostate Cancer
		Intervention:	Drug: Oral Estramustine, Oral Etoposide, Intravenous Paclitaxel

28	Active, not recruiting	Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy
		Condition:	Prostate Cancer
		Interventions:	Drug: docetaxel; Drug: estramustine phosphate sodium; Drug: thalidomide

29	Active, not recruiting	Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer
		Condition:	Prostate Cancer
		Interventions:	Drug: doxorubicin hydrochloride; Drug: estramustine phosphate sodium; Drug: etoposide; Drug: ketoconazole; Drug: paclitaxel; Drug: vinblastine

30	Active, not recruiting	Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy
		Condition:	Prostate Cancer
		Interventions:	Drug: docetaxel; Drug: estramustine phosphate sodium; Drug: mitoxantrone hydrochloride; Drug: prednisone

31	Active, not recruiting	Combination Chemotherapy in Treating Patients With Advanced Cancer
		Conditions:	Leukemia; Lymphoma; Sarcoma; Unspecified Adult Solid Tumor, Protocol Specific
		Interventions:	Drug: estramustine phosphate sodium; Drug: paclitaxel; Drug: vinorelbine ditartrate

32	Active, not recruiting	Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer
		Condition:	Prostate Cancer
		Interventions:	Drug: bicalutamide; Drug: docetaxel; Drug: estramustine phosphate sodium; Drug: leuprolide acetate

33	Active, not recruiting	Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer
		Conditions:	Prostate Cancer; Thromboembolism
		Interventions:	Drug: docetaxel; Drug: doxorubicin hydrochloride; Drug: estramustine phosphate sodium; Drug: ketoconazole; Drug: warfarin

34	Active, not recruiting	Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
		Condition:	Prostate Cancer
		Interventions:	Drug: carboplatin; Drug: estramustine phosphate sodium; Drug: goserelin; Drug: leuprolide acetate; Drug: paclitaxel; Procedure: endocrine drug therapy

35	Completed	Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
		Condition:	Prostate Cancer
		Interventions:	Drug: carboplatin; Drug: docetaxel; Drug: estramustine phosphate sodium; Drug: filgrastim

36	Active, not recruiting	Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
		Condition:	Prostate Cancer
		Interventions:	Drug: docetaxel; Drug: estramustine phosphate sodium; Drug: mitoxantrone hydrochloride; Drug: prednisone

37	Active, not recruiting	Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer
		Condition:	Kidney Cancer
		Interventions:	Drug: estramustine phosphate sodium; Drug: prednisone; Drug: vinorelbine ditartrate

38	Active, not recruiting	Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer
		Condition:	Prostate Cancer
		Interventions:	Drug: bevacizumab; Drug: docetaxel; Drug: estramustine phosphate sodium

39	Active, not recruiting	Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
		Condition:	Prostate Cancer
		Interventions:	Drug: estramustine phosphate sodium; Drug: isotretinoin; Drug: mitoxantrone hydrochloride; Drug: paclitaxel; Drug: recombinant interferon alfa; Drug: vinorelbine ditartrate

40	Active, not recruiting	Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
		Condition:	Prostate Cancer
		Interventions:	Drug: bicalutamide; Drug: estramustine phosphate sodium; Drug: etoposide; Drug: flutamide; Drug: goserelin; Drug: leuprolide acetate; Drug: nilutamide; Drug: paclitaxel

41	Active, not recruiting	Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer
		Condition:	Prostate Cancer
		Interventions:	Drug: carboplatin; Drug: estramustine phosphate sodium; Drug: goserelin; Drug: leuprolide acetate; Drug: paclitaxel; Procedure: neoadjuvant therapy; Procedure: radiation therapy

42	Active, not recruiting	Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer
		Condition:	Prostate Cancer
		Interventions:	Drug: docetaxel; Drug: estramustine phosphate sodium; Drug: ketoconazole; Drug: therapeutic hydrocortisone

43	Active, not recruiting	Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer
		Condition:	Prostate Cancer
		Interventions:	Drug: bicalutamide; Drug: estramustine phosphate sodium; Drug: etoposide; Drug: flutamide; Drug: paclitaxel; Procedure: radiation therapy; Procedure: releasing hormone agonist therapy

44	Active, not recruiting	Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate
		Condition:	Hormone-Refractory Prostate Cancer
		Intervention:	Drug: Zometa

45	Active, not recruiting	Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
		Condition:	Prostate Cancer
		Interventions:	Drug: bicalutamide; Drug: docetaxel; Drug: doxorubicin hydrochloride; Drug: estramustine phosphate sodium; Drug: flutamide; Drug: ketoconazole; Drug: paclitaxel; Drug: vinblastine; Procedure: releasing hormone agonist therapy

46	Active, not recruiting	Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer
		Condition:	Prostate Cancer
		Interventions:	Drug: bicalutamide; Drug: doxorubicin hydrochloride; Drug: estramustine phosphate sodium; Drug: flutamide; Drug: ketoconazole; Drug: nilutamide; Drug: therapeutic hydrocortisone; Drug: vinblastine; Procedure: conventional surgery; Procedure: endocrine drug therapy

47	Recruiting	Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
		Condition:	Prostate Cancer
		Interventions:	Drug: docetaxel; Drug: doxorubicin hydrochloride; Drug: estramustine phosphate sodium; Drug: ketoconazole; Drug: prednisone; Drug: strontium chloride Sr 89; Drug: vinblastine

48	Terminated	Trial of Docetaxel-Samarium in Patients With Hormone-Refractory Advanced Prostate Cancer
		Condition:	Prostate Cancer
		Intervention:	Drug: docetaxel and samarium

RSS Feed for studies found by your search that were received in the last 14 days

Download Options